match_id	MYCN_TPM	MYCN_CN	MYCN_CN_status	molecular_subtype	Kids_First_Participant_ID	Kids_First_Biospecimen_ID	sample_id
PAISNS_01_Solid Tissue_Primary Tumor	35.59	NA	NA	NBL, MYCN amplified	PAISNS	TARGET-30-PAISNS-01A-01D.M	01
PAISNS_01_Solid Tissue_Primary Tumor	35.59	NA	NA	NBL, MYCN amplified	PAISNS	TARGET-30-PAISNS-01A-01R	01
PAKZRH_01_Solid Tissue_Primary Tumor	19.5	NA	NA	NBL, MYCN amplified	PAKZRH	TARGET-30-PAKZRH-01A-01D.M	01
PAKZRH_01_Solid Tissue_Primary Tumor	19.5	NA	NA	NBL, MYCN amplified	PAKZRH	TARGET-30-PAKZRH-01A-01R	01
PALKUC_01_Solid Tissue_Primary Tumor	147.41	NA	NA	NBL, MYCN amplified	PALKUC	TARGET-30-PALKUC-01A-01R	01
PALNVP_01_Solid Tissue_Primary Tumor	22.36	NA	NA	NBL, MYCN amplified	PALNVP	TARGET-30-PALNVP-01A-01D.M	01
PALNVP_01_Solid Tissue_Primary Tumor	22.36	NA	NA	NBL, MYCN amplified	PALNVP	TARGET-30-PALNVP-01A-01R	01
PALUYS_01_Solid Tissue_Primary Tumor	64.75	NA	NA	NBL, MYCN amplified	PALUYS	TARGET-30-PALUYS-01A-01R	01
PALVKK_01_Solid Tissue_Primary Tumor	11.63	NA	NA	NBL, MYCN non-amplified	PALVKK	TARGET-30-PALVKK-01A-01R	01
PALXTB_01_Solid Tissue_Primary Tumor	35.21	NA	NA	NBL, MYCN amplified	PALXTB	TARGET-30-PALXTB-01A-01D.M	01
PALXTB_01_Solid Tissue_Primary Tumor	35.21	NA	NA	NBL, MYCN amplified	PALXTB	TARGET-30-PALXTB-01A-01R	01
PAMBMJ_01_Solid Tissue_Primary Tumor	71.2	NA	NA	NBL, MYCN amplified	PAMBMJ	TARGET-30-PAMBMJ-01A-01R	01
PAMEZH_01_Solid Tissue_Primary Tumor	121.89	NA	NA	NBL, MYCN non-amplified	PAMEZH	TARGET-30-PAMEZH-01A-01R	01
PAMNLH_01_Solid Tissue_Primary Tumor	29.77	NA	NA	NBL, MYCN amplified	PAMNLH	TARGET-30-PAMNLH-01A-01D.M	01
PAMNLH_01_Solid Tissue_Primary Tumor	29.77	NA	NA	NBL, MYCN amplified	PAMNLH	TARGET-30-PAMNLH-01A-01R	01
PANBJH_01_Solid Tissue_Primary Tumor	81.56	NA	NA	NBL, MYCN amplified	PANBJH	TARGET-30-PANBJH-01A-01R	01
PANGXK_01_Solid Tissue_Primary Tumor	3.28	NA	NA	NBL, MYCN amplified	PANGXK	TARGET-30-PANGXK-01A-01R	01
PANJLH_01_Solid Tissue_Primary Tumor	403.51	NA	NA	NBL, MYCN amplified	PANJLH	TARGET-30-PANJLH-01A-01R	01
PANNMS_01_Solid Tissue_Primary Tumor	73.96	NA	NA	NBL, MYCN amplified	PANNMS	TARGET-30-PANNMS-01A-01D.M	01
PANNMS_01_Solid Tissue_Primary Tumor	73.96	NA	NA	NBL, MYCN amplified	PANNMS	TARGET-30-PANNMS-01A-01R	01
PANRRW_01_Solid Tissue_Primary Tumor	42.67	NA	NA	NBL, MYCN amplified	PANRRW	TARGET-30-PANRRW-01A-01D.M	01
PANRRW_01_Solid Tissue_Primary Tumor	42.67	NA	NA	NBL, MYCN amplified	PANRRW	TARGET-30-PANRRW-01A-01R	01
PANZRV_01_Solid Tissue_Primary Tumor	73.06	NA	NA	NBL, MYCN amplified	PANZRV	TARGET-30-PANZRV-01A-01R	01
PAPICY_01_Solid Tissue_Primary Tumor	52.53	NA	NA	NBL, MYCN amplified	PAPICY	TARGET-30-PAPICY-01A-01D.M	01
PAPICY_01_Solid Tissue_Primary Tumor	52.53	NA	NA	NBL, MYCN amplified	PAPICY	TARGET-30-PAPICY-01A-01R	01
PAPTCR_01_Solid Tissue_Primary Tumor	5.71	2	neutral	NBL, MYCN amplified	PAPTCR	TARGET-30-PAPTCR-01A-01D	01
PAPTCR_01_Solid Tissue_Primary Tumor	5.71	2	neutral	NBL, MYCN amplified	PAPTCR	TARGET-30-PAPTCR-01A-01D.M	01
PAPTCR_01_Solid Tissue_Primary Tumor	5.71	2	neutral	NBL, MYCN amplified	PAPTCR	TARGET-30-PAPTCR-01A-01R	01
PAPTDH_01_Solid Tissue_Primary Tumor	38.65	NA	NA	NBL, MYCN amplified	PAPTDH	TARGET-30-PAPTDH-01A-01D.M	01
PAPTDH_01_Solid Tissue_Primary Tumor	38.65	NA	NA	NBL, MYCN amplified	PAPTDH	TARGET-30-PAPTDH-01A-01R	01
PAPUEB_01_Solid Tissue_Primary Tumor	20.09	NA	NA	NBL, MYCN amplified	PAPUEB	TARGET-30-PAPUEB-01A-01R	01
PAPUNH_01_Solid Tissue_Primary Tumor	2481.33	NA	NA	NBL, MYCN amplified	PAPUNH	TARGET-30-PAPUNH-01A-01D.M	01
PAPUNH_01_Solid Tissue_Primary Tumor	2481.33	NA	NA	NBL, MYCN amplified	PAPUNH	TARGET-30-PAPUNH-01A-01R	01
PAPVEB_04_Bone Marrow_Recurrence	11.44	NA	NA	NBL, MYCN non-amplified	PAPVEB	TARGET-30-PAPVEB-04A-01D.M	04
PAPVEB_04_Bone Marrow_Recurrence	11.44	NA	NA	NBL, MYCN non-amplified	PAPVEB	TARGET-30-PAPVEB-04A-01R	04
PAPZYP_01_Solid Tissue_Primary Tumor	404.52	NA	NA	NBL, MYCN amplified	PAPZYP	TARGET-30-PAPZYP-01A-01D.M	01
PAPZYP_01_Solid Tissue_Primary Tumor	404.52	NA	NA	NBL, MYCN amplified	PAPZYP	TARGET-30-PAPZYP-01A-01R	01
PARACM_01_Solid Tissue_Primary Tumor	35.88	NA	NA	NBL, MYCN amplified	PARACM	TARGET-30-PARACM-01A-01D.M	01
PARACM_01_Solid Tissue_Primary Tumor	35.88	NA	NA	NBL, MYCN amplified	PARACM	TARGET-30-PARACM-01A-01R	01
PARBAJ_01_Solid Tissue_Primary Tumor	20.35	NA	NA	NBL, MYCN amplified	PARBAJ	TARGET-30-PARBAJ-01A-01D.M	01
PARBAJ_01_Solid Tissue_Primary Tumor	20.35	NA	NA	NBL, MYCN amplified	PARBAJ	TARGET-30-PARBAJ-01A-01R	01
PARBAJ_02_Solid Tissue_Recurrence	11.17	NA	NA	NBL, MYCN non-amplified	PARBAJ	TARGET-30-PARBAJ-02A-01D.M	02
PARBAJ_02_Solid Tissue_Recurrence	11.17	NA	NA	NBL, MYCN non-amplified	PARBAJ	TARGET-30-PARBAJ-02A-01R	02
PARFRE_01_Solid Tissue_Primary Tumor	37.8	NA	NA	NBL, MYCN amplified	PARFRE	TARGET-30-PARFRE-01A-01D.M	01
PARFRE_01_Solid Tissue_Primary Tumor	37.8	NA	NA	NBL, MYCN amplified	PARFRE	TARGET-30-PARFRE-01A-01R	01
PARHAM_01_Solid Tissue_Primary Tumor	29.37	NA	NA	NBL, MYCN amplified	PARHAM	TARGET-30-PARHAM-01A-01D.M	01
PARHAM_01_Solid Tissue_Primary Tumor	29.37	NA	NA	NBL, MYCN amplified	PARHAM	TARGET-30-PARHAM-01A-01R	01
PARHAM_02_Solid Tissue_Recurrence	11.26	NA	NA	NBL, MYCN non-amplified	PARHAM	TARGET-30-PARHAM-02A-01D.M	02
PARHAM_02_Solid Tissue_Recurrence	11.26	NA	NA	NBL, MYCN non-amplified	PARHAM	TARGET-30-PARHAM-02A-01R	02
PARJVP_01_Solid Tissue_Primary Tumor	70.22	NA	NA	NBL, MYCN amplified	PARJVP	TARGET-30-PARJVP-01A-01D.M	01
PARJVP_01_Solid Tissue_Primary Tumor	70.22	NA	NA	NBL, MYCN amplified	PARJVP	TARGET-30-PARJVP-01A-01R	01
PARNNC_01_Solid Tissue_Primary Tumor	42.52	NA	NA	NBL, MYCN amplified	PARNNC	TARGET-30-PARNNC-01A-01D.M	01
PARNNC_01_Solid Tissue_Primary Tumor	42.52	NA	NA	NBL, MYCN amplified	PARNNC	TARGET-30-PARNNC-01A-01R	01
PARTRP_01_Solid Tissue_Primary Tumor	16.43	NA	NA	NBL, MYCN amplified	PARTRP	BS_4RX1AAVV	01
PARTRP_01_Solid Tissue_Primary Tumor	16.43	NA	NA	NBL, MYCN amplified	PARTRP	BS_S0B4WASX	01
PARTRP_01_Solid Tissue_Primary Tumor	16.43	NA	NA	NBL, MYCN amplified	PARTRP	TARGET-30-PARTRP-01A-01D	01
PARUTJ_01_Solid Tissue_Primary Tumor	0.41	NA	NA	NBL, MYCN non-amplified	PARUTJ	BS_K2K5YSDS	01
PARUTJ_01_Solid Tissue_Primary Tumor	0.41	NA	NA	NBL, MYCN non-amplified	PARUTJ	BS_S5KDWVEA	01
PARUTJ_01_Solid Tissue_Primary Tumor	0.41	NA	NA	NBL, MYCN non-amplified	PARUTJ	TARGET-30-PARUTJ-01A-01D	01
PARUZA_01_Solid Tissue_Primary Tumor	0.49	NA	NA	NBL, MYCN non-amplified	PARUZA	BS_808H2FQN	01
PARUZA_01_Solid Tissue_Primary Tumor	0.49	NA	NA	NBL, MYCN non-amplified	PARUZA	BS_ERHKS2Y7	01
PARWEV_01_Solid Tissue_Primary Tumor	33.86	NA	NA	NBL, MYCN amplified	PARWEV	BS_C8T56CWR	01
PARWEV_01_Solid Tissue_Primary Tumor	33.86	NA	NA	NBL, MYCN amplified	PARWEV	BS_DBXCETW2	01
PARWEV_01_Solid Tissue_Primary Tumor	33.86	NA	NA	NBL, MYCN amplified	PARWEV	TARGET-30-PARWEV-01A-01D	01
PARYAG_01_Solid Tissue_Primary Tumor	1.84	NA	NA	NBL, MYCN non-amplified	PARYAG	BS_29MQMSCM	01
PARYAG_01_Solid Tissue_Primary Tumor	1.84	NA	NA	NBL, MYCN non-amplified	PARYAG	BS_YZJ5YQ12	01
PARYRJ_01_Solid Tissue_Primary Tumor	26.4	NA	NA	NBL, MYCN amplified	PARYRJ	BS_92YFTG9R	01
PARYRJ_01_Solid Tissue_Primary Tumor	26.4	NA	NA	NBL, MYCN amplified	PARYRJ	BS_JY850J9G	01
PARYRJ_01_Solid Tissue_Primary Tumor	26.4	NA	NA	NBL, MYCN amplified	PARYRJ	TARGET-30-PARYRJ-01A-01D	01
PARZBH_01_Solid Tissue_Primary Tumor	22.7	NA	NA	NBL, MYCN amplified	PARZBH	BS_BG0ZDND2	01
PARZBH_01_Solid Tissue_Primary Tumor	22.7	NA	NA	NBL, MYCN amplified	PARZBH	BS_F6MNG2S0	01
PARZBH_01_Solid Tissue_Primary Tumor	22.7	NA	NA	NBL, MYCN amplified	PARZBH	TARGET-30-PARZBH-01A-01D	01
PARZCJ_01_Solid Tissue_Primary Tumor	22.125	NA	NA	NBL, MYCN amplified	PARZCJ	BS_1G3QX306	01
PARZCJ_01_Solid Tissue_Primary Tumor	22.125	NA	NA	NBL, MYCN amplified	PARZCJ	BS_FHNTKFVJ	01
PARZCJ_01_Solid Tissue_Primary Tumor	22.125	NA	NA	NBL, MYCN amplified	PARZCJ	TARGET-30-PARZCJ-01A-01D.M	01
PARZCJ_01_Solid Tissue_Primary Tumor	22.125	NA	NA	NBL, MYCN amplified	PARZCJ	TARGET-30-PARZCJ-01A-01R	01
PARZHA_01_Solid Tissue_Primary Tumor	68.06	NA	NA	NBL, MYCN amplified	PARZHA	TARGET-30-PARZHA-01A-01D.M	01
PARZHA_01_Solid Tissue_Primary Tumor	68.06	NA	NA	NBL, MYCN amplified	PARZHA	TARGET-30-PARZHA-01A-01R	01
PASAGA_01_Solid Tissue_Primary Tumor	11.82	NA	NA	NBL, MYCN non-amplified	PASAGA	BS_7MXT22QP	01
PASAGA_01_Solid Tissue_Primary Tumor	11.82	NA	NA	NBL, MYCN non-amplified	PASAGA	BS_9R8GFR36	01
PASAHC_01_Solid Tissue_Primary Tumor	20.59	NA	NA	NBL, MYCN amplified	PASAHC	BS_AFRGW493	01
PASAHC_01_Solid Tissue_Primary Tumor	20.59	NA	NA	NBL, MYCN amplified	PASAHC	BS_Z2G9EG1X	01
PASAHC_01_Solid Tissue_Primary Tumor	20.59	NA	NA	NBL, MYCN amplified	PASAHC	TARGET-30-PASAHC-01A-01D	01
PASAVJ_01_Solid Tissue_Primary Tumor	21.16	NA	NA	NBL, MYCN amplified	PASAVJ	BS_28ZRHXX8	01
PASAVJ_01_Solid Tissue_Primary Tumor	21.16	NA	NA	NBL, MYCN amplified	PASAVJ	BS_J3707KE2	01
PASAVJ_01_Solid Tissue_Primary Tumor	21.16	NA	NA	NBL, MYCN amplified	PASAVJ	TARGET-30-PASAVJ-01A-01D	01
PASCFC_01_Solid Tissue_Primary Tumor	54.22	NA	NA	NBL, MYCN amplified	PASCFC	TARGET-30-PASCFC-01A-01D.M	01
PASCFC_01_Solid Tissue_Primary Tumor	54.22	NA	NA	NBL, MYCN amplified	PASCFC	TARGET-30-PASCFC-01A-01R	01
PASCTR_01_Solid Tissue_Primary Tumor	38.9	NA	NA	NBL, MYCN amplified	PASCTR	TARGET-30-PASCTR-01A-01D.M	01
PASCTR_01_Solid Tissue_Primary Tumor	38.9	NA	NA	NBL, MYCN amplified	PASCTR	TARGET-30-PASCTR-01A-01R	01
PASDYT_01_Solid Tissue_Primary Tumor	17.46	NA	NA	NBL, MYCN amplified	PASDYT	BS_B6E0477K	01
PASDYT_01_Solid Tissue_Primary Tumor	17.46	NA	NA	NBL, MYCN amplified	PASDYT	BS_N13KZYRR	01
PASDYT_01_Solid Tissue_Primary Tumor	17.46	NA	NA	NBL, MYCN amplified	PASDYT	TARGET-30-PASDYT-01A-01D	01
PASFCG_01_Solid Tissue_Primary Tumor	24.8	NA	NA	NBL, MYCN amplified	PASFCG	BS_PQFKEKEW	01
PASFCG_01_Solid Tissue_Primary Tumor	24.8	NA	NA	NBL, MYCN amplified	PASFCG	BS_WR5VE59B	01
PASFCG_01_Solid Tissue_Primary Tumor	24.8	NA	NA	NBL, MYCN amplified	PASFCG	TARGET-30-PASFCG-01A-01D	01
PASFEU_01_Solid Tissue_Primary Tumor	1.62	NA	NA	NBL, MYCN non-amplified	PASFEU	BS_KE5D12KG	01
PASFEU_01_Solid Tissue_Primary Tumor	1.62	NA	NA	NBL, MYCN non-amplified	PASFEU	BS_W3ZSVEVP	01
PASFIC_01_Solid Tissue_Primary Tumor	23.605	NA	NA	NBL, MYCN amplified	PASFIC	BS_DYHEFXJC	01
PASFIC_01_Solid Tissue_Primary Tumor	23.605	NA	NA	NBL, MYCN amplified	PASFIC	BS_W22EEJCZ	01
PASFIC_01_Solid Tissue_Primary Tumor	23.605	NA	NA	NBL, MYCN amplified	PASFIC	TARGET-30-PASFIC-01A-01D.M	01
PASFIC_01_Solid Tissue_Primary Tumor	23.605	NA	NA	NBL, MYCN amplified	PASFIC	TARGET-30-PASFIC-01A-01R	01
PASGAP_02_Solid Tissue_Recurrence	10.98	NA	NA	NBL, MYCN non-amplified	PASGAP	TARGET-30-PASGAP-02A-01D.M	02
PASGAP_02_Solid Tissue_Recurrence	10.98	NA	NA	NBL, MYCN non-amplified	PASGAP	TARGET-30-PASGAP-02A-01R	02
PASGBE_01_Solid Tissue_Primary Tumor	2.34	NA	NA	NBL, MYCN amplified	PASGBE	BS_43R2B7DR	01
PASGGD_01_Solid Tissue_Primary Tumor	13.74	NA	NA	NBL, MYCN non-amplified	PASGGD	BS_A2HY1DZA	01
PASGGD_01_Solid Tissue_Primary Tumor	13.74	NA	NA	NBL, MYCN non-amplified	PASGGD	BS_QKTJ4QY9	01
PASHFA_01_Solid Tissue_Primary Tumor	422.71	NA	NA	NBL, MYCN amplified	PASHFA	TARGET-30-PASHFA-01A-01D.M	01
PASHFA_01_Solid Tissue_Primary Tumor	422.71	NA	NA	NBL, MYCN amplified	PASHFA	TARGET-30-PASHFA-01A-01R	01
PASJZC_01_Solid Tissue_Primary Tumor	35.63	NA	NA	NBL, MYCN amplified	PASJZC	TARGET-30-PASJZC-01A-01D.M	01
PASJZC_01_Solid Tissue_Primary Tumor	35.63	NA	NA	NBL, MYCN amplified	PASJZC	TARGET-30-PASJZC-01A-01R	01
PASKFM_01_Solid Tissue_Primary Tumor	50.58	NA	NA	NBL, MYCN amplified	PASKFM	BS_EE5Z0Z4J	01
PASKFM_01_Solid Tissue_Primary Tumor	50.58	NA	NA	NBL, MYCN amplified	PASKFM	BS_JQ0XD1K9	01
PASKWI_01_Solid Tissue_Primary Tumor	0.86	NA	NA	NBL, MYCN non-amplified	PASKWI	BS_3V34S6KM	01
PASKZT_01_Solid Tissue_Primary Tumor	2.05	NA	NA	NBL, MYCN amplified	PASKZT	BS_CKVK1AYV	01
PASKZT_01_Solid Tissue_Primary Tumor	2.05	NA	NA	NBL, MYCN amplified	PASKZT	BS_CZ7DWCPE	01
PASKZT_01_Solid Tissue_Primary Tumor	2.05	NA	NA	NBL, MYCN amplified	PASKZT	TARGET-30-PASKZT-01A-01D	01
PASLIH_01_Solid Tissue_Primary Tumor	20.29	NA	NA	NBL, MYCN amplified	PASLIH	BS_6KH6CXMH	01
PASLIH_01_Solid Tissue_Primary Tumor	20.29	NA	NA	NBL, MYCN amplified	PASLIH	BS_HW9CGZ29	01
PASLIH_01_Solid Tissue_Primary Tumor	20.29	NA	NA	NBL, MYCN amplified	PASLIH	TARGET-30-PASLIH-01A-01D	01
PASLPG_01_Solid Tissue_Primary Tumor	8.53	NA	NA	NBL, MYCN amplified	PASLPG	BS_9C595Y9M	01
PASLPG_01_Solid Tissue_Primary Tumor	8.53	NA	NA	NBL, MYCN amplified	PASLPG	BS_V7B79J5R	01
PASLPG_01_Solid Tissue_Primary Tumor	8.53	NA	NA	NBL, MYCN amplified	PASLPG	TARGET-30-PASLPG-01A-01D	01
PASMDM_01_Solid Tissue_Primary Tumor	37.6	NA	NA	NBL, MYCN amplified	PASMDM	TARGET-30-PASMDM-01A-01D.M	01
PASMDM_01_Solid Tissue_Primary Tumor	37.6	NA	NA	NBL, MYCN amplified	PASMDM	TARGET-30-PASMDM-01A-01R	01
PASNII_01_Solid Tissue_Primary Tumor	19.18	NA	NA	NBL, MYCN amplified	PASNII	BS_A3198WFE	01
PASNML_01_Solid Tissue_Primary Tumor	72.94	NA	NA	NBL, MYCN amplified	PASNML	TARGET-30-PASNML-01A-01D.M	01
PASNML_01_Solid Tissue_Primary Tumor	72.94	NA	NA	NBL, MYCN amplified	PASNML	TARGET-30-PASNML-01A-01R	01
PASNPG_01_Solid Tissue_Primary Tumor	39	NA	NA	NBL, MYCN amplified	PASNPG	TARGET-30-PASNPG-01A-01D.M	01
PASNPG_01_Solid Tissue_Primary Tumor	39	NA	NA	NBL, MYCN amplified	PASNPG	TARGET-30-PASNPG-01A-01R	01
PASNPG_02_Solid Tissue_Recurrence	24.6	NA	NA	NBL, MYCN amplified	PASNPG	TARGET-30-PASNPG-02A-01D.M	02
PASNPG_02_Solid Tissue_Recurrence	24.6	NA	NA	NBL, MYCN amplified	PASNPG	TARGET-30-PASNPG-02A-01R	02
PASPBZ_01_Solid Tissue_Primary Tumor	16.63	NA	NA	NBL, MYCN amplified	PASPBZ	TARGET-30-PASPBZ-01A-01D.M	01
PASPBZ_01_Solid Tissue_Primary Tumor	16.63	NA	NA	NBL, MYCN amplified	PASPBZ	TARGET-30-PASPBZ-01A-01R	01
PASSMV_01_Solid Tissue_Primary Tumor	7.74	NA	NA	NBL, MYCN amplified	PASSMV	BS_C9YD10Y4	01
PASSMV_01_Solid Tissue_Primary Tumor	7.74	NA	NA	NBL, MYCN amplified	PASSMV	BS_EXEE6TDK	01
PASSWW_01_Solid Tissue_Primary Tumor	13.53	NA	NA	NBL, MYCN non-amplified	PASSWW	BS_8S0EDFTP	01
PASSWW_01_Solid Tissue_Primary Tumor	13.53	NA	NA	NBL, MYCN non-amplified	PASSWW	BS_K9VNW7JD	01
PASSWW_01_Solid Tissue_Primary Tumor	13.53	NA	NA	NBL, MYCN non-amplified	PASSWW	TARGET-30-PASSWW-01A-01D.M	01
PASSWW_01_Solid Tissue_Primary Tumor	13.53	NA	NA	NBL, MYCN non-amplified	PASSWW	TARGET-30-PASSWW-01A-01R	01
PASTRD_01_Solid Tissue_Primary Tumor	3.16	NA	NA	NBL, MYCN amplified	PASTRD	BS_RQZZ6T97	01
PASTRD_01_Solid Tissue_Primary Tumor	3.16	NA	NA	NBL, MYCN amplified	PASTRD	BS_S01DMJ5X	01
PASTWY_01_Solid Tissue_Primary Tumor	42.87	NA	NA	NBL, MYCN amplified	PASTWY	BS_8EX2H96N	01
PASTWY_01_Solid Tissue_Primary Tumor	42.87	NA	NA	NBL, MYCN amplified	PASTWY	BS_C3KT9THS	01
PASTWY_01_Solid Tissue_Primary Tumor	42.87	NA	NA	NBL, MYCN amplified	PASTWY	TARGET-30-PASTWY-01A-01D	01
PASTZR_01_Solid Tissue_Primary Tumor	23.06	NA	NA	NBL, MYCN amplified	PASTZR	BS_HA1N9VCX	01
PASTZR_01_Solid Tissue_Primary Tumor	23.06	NA	NA	NBL, MYCN amplified	PASTZR	BS_PS8TB6Z0	01
PASUFD_01_Solid Tissue_Primary Tumor	5.99	NA	NA	NBL, MYCN amplified	PASUFD	BS_2XTH5QRD	01
PASUFD_01_Solid Tissue_Primary Tumor	5.99	NA	NA	NBL, MYCN amplified	PASUFD	BS_Y4V9JXG4	01
PASUMK_01_Solid Tissue_Primary Tumor	0.6	NA	NA	NBL, MYCN non-amplified	PASUMK	BS_9CPZ5R1T	01
PASUMK_01_Solid Tissue_Primary Tumor	0.6	NA	NA	NBL, MYCN non-amplified	PASUMK	BS_RW0JJ9BQ	01
PASUML_01_Solid Tissue_Primary Tumor	56.17	NA	NA	NBL, MYCN amplified	PASUML	TARGET-30-PASUML-01A-01D.M	01
PASUML_01_Solid Tissue_Primary Tumor	56.17	NA	NA	NBL, MYCN amplified	PASUML	TARGET-30-PASUML-01A-01R	01
PASUVU_01_Solid Tissue_Primary Tumor	24.63	NA	NA	NBL, MYCN amplified	PASUVU	BS_9PRG9CJC	01
PASUVU_01_Solid Tissue_Primary Tumor	24.63	NA	NA	NBL, MYCN amplified	PASUVU	BS_MGHRCZEV	01
PASVXS_01_Solid Tissue_Primary Tumor	9.01	NA	NA	NBL, MYCN amplified	PASVXS	BS_2SFR8Z1P	01
PASVXS_01_Solid Tissue_Primary Tumor	9.01	NA	NA	NBL, MYCN amplified	PASVXS	BS_8T0AKNMJ	01
PASWMY_01_Solid Tissue_Primary Tumor	13	NA	NA	NBL, MYCN non-amplified	PASWMY	BS_3CTRC269	01
PASWMY_01_Solid Tissue_Primary Tumor	13	NA	NA	NBL, MYCN non-amplified	PASWMY	BS_TT4PHFV7	01
PASXWF_01_Solid Tissue_Primary Tumor	2.17	NA	NA	NBL, MYCN amplified	PASXWF	BS_CD6WEHG9	01
PASXWF_01_Solid Tissue_Primary Tumor	2.17	NA	NA	NBL, MYCN amplified	PASXWF	BS_SPGHWHXY	01
PASYYZ_01_Solid Tissue_Primary Tumor	1.27	NA	NA	NBL, MYCN non-amplified	PASYYZ	BS_EPZ2H50J	01
PASYYZ_01_Solid Tissue_Primary Tumor	1.27	NA	NA	NBL, MYCN non-amplified	PASYYZ	BS_XQSEQPAZ	01
PASZKE_01_Solid Tissue_Primary Tumor	16.17	NA	NA	NBL, MYCN amplified	PASZKE	BS_XPTREBJD	01
PASZKE_01_Solid Tissue_Primary Tumor	16.17	NA	NA	NBL, MYCN amplified	PASZKE	TARGET-30-PASZKE-01A-01D.M	01
PASZKE_01_Solid Tissue_Primary Tumor	16.17	NA	NA	NBL, MYCN amplified	PASZKE	TARGET-30-PASZKE-01A-01R	01
PASZRF_01_Solid Tissue_Primary Tumor	17.59	NA	NA	NBL, MYCN amplified	PASZRF	BS_FRY5NFRY	01
PASZRF_01_Solid Tissue_Primary Tumor	17.59	NA	NA	NBL, MYCN amplified	PASZRF	BS_Y9BHAPG3	01
PATAYJ_01_Solid Tissue_Primary Tumor	40.96	NA	NA	NBL, MYCN amplified	PATAYJ	TARGET-30-PATAYJ-01A-01D.M	01
PATAYJ_01_Solid Tissue_Primary Tumor	40.96	NA	NA	NBL, MYCN amplified	PATAYJ	TARGET-30-PATAYJ-01A-01R	01
PATBCM_01_Solid Tissue_Primary Tumor	5.2	NA	NA	NBL, MYCN amplified	PATBCM	BS_FE3BY6DT	01
PATBCM_01_Solid Tissue_Primary Tumor	5.2	NA	NA	NBL, MYCN amplified	PATBCM	BS_W09W6AAS	01
PATBFN_01_Solid Tissue_Primary Tumor	33.83	NA	NA	NBL, MYCN amplified	PATBFN	BS_HCWEF4QN	01
PATBFN_01_Solid Tissue_Primary Tumor	33.83	NA	NA	NBL, MYCN amplified	PATBFN	BS_Z3BZ01S1	01
PATBGF_01_Solid Tissue_Primary Tumor	6.68	NA	NA	NBL, MYCN amplified	PATBGF	BS_7W42FH5A	01
PATBGF_01_Solid Tissue_Primary Tumor	6.68	NA	NA	NBL, MYCN amplified	PATBGF	BS_M462FWS9	01
PATBHY_01_Solid Tissue_Primary Tumor	16.32	NA	NA	NBL, MYCN amplified	PATBHY	BS_NQP7B1SY	01
PATBHY_01_Solid Tissue_Primary Tumor	16.32	NA	NA	NBL, MYCN amplified	PATBHY	TARGET-30-PATBHY-01A-01D	01
PATCMD_01_Solid Tissue_Primary Tumor	43.2	NA	NA	NBL, MYCN amplified	PATCMD	BS_MYNJDVWV	01
PATCVK_01_Solid Tissue_Primary Tumor	15.78	NA	NA	NBL, MYCN amplified	PATCVK	BS_F92J3KBA	01
PATCVK_01_Solid Tissue_Primary Tumor	15.78	NA	NA	NBL, MYCN amplified	PATCVK	BS_JWXQFZY9	01
PATDKL_01_Solid Tissue_Primary Tumor	3.77	NA	NA	NBL, MYCN amplified	PATDKL	BS_TWN989ZD	01
PATDKL_01_Solid Tissue_Primary Tumor	3.77	NA	NA	NBL, MYCN amplified	PATDKL	BS_YF5NCTGA	01
PATDWR_01_Solid Tissue_Primary Tumor	15.89	NA	NA	NBL, MYCN amplified	PATDWR	BS_4A1CKAXN	01
PATDWR_01_Solid Tissue_Primary Tumor	15.89	NA	NA	NBL, MYCN amplified	PATDWR	BS_XWKDJ2M6	01
PATEEE_01_Solid Tissue_Primary Tumor	8.55	NA	NA	NBL, MYCN amplified	PATEEE	BS_WFZG82XZ	01
PATEEE_01_Solid Tissue_Primary Tumor	8.55	NA	NA	NBL, MYCN amplified	PATEEE	BS_XFFQR05Z	01
PATETW_01_Solid Tissue_Primary Tumor	17.35	NA	NA	NBL, MYCN amplified	PATETW	BS_3GRJH3PS	01
PATETW_01_Solid Tissue_Primary Tumor	17.35	NA	NA	NBL, MYCN amplified	PATETW	BS_K5DHTP34	01
PATFTR_01_Solid Tissue_Primary Tumor	27.57	NA	NA	NBL, MYCN amplified	PATFTR	BS_GTFHNG3R	01
PATFTR_01_Solid Tissue_Primary Tumor	27.57	NA	NA	NBL, MYCN amplified	PATFTR	BS_XQC9PNZP	01
PATFTR_01_Solid Tissue_Primary Tumor	27.57	NA	NA	NBL, MYCN amplified	PATFTR	TARGET-30-PATFTR-01A-01D	01
PATGIW_01_Solid Tissue_Primary Tumor	6.43	NA	NA	NBL, MYCN amplified	PATGIW	BS_JBKQ59CW	01
PATGIW_01_Solid Tissue_Primary Tumor	6.43	NA	NA	NBL, MYCN amplified	PATGIW	BS_VKK21QBZ	01
PATGJU_01_Solid Tissue_Primary Tumor	26.34	NA	NA	NBL, MYCN amplified	PATGJU	TARGET-30-PATGJU-01A-01D.M	01
PATGJU_01_Solid Tissue_Primary Tumor	26.34	NA	NA	NBL, MYCN amplified	PATGJU	TARGET-30-PATGJU-01A-01R	01
PATHKB_01_Solid Tissue_Primary Tumor	88.44	NA	NA	NBL, MYCN amplified	PATHKB	TARGET-30-PATHKB-01A-01D.M	01
PATHKB_01_Solid Tissue_Primary Tumor	88.44	NA	NA	NBL, MYCN amplified	PATHKB	TARGET-30-PATHKB-01A-01R	01
PATIIT_01_Solid Tissue_Primary Tumor	42.43	NA	NA	NBL, MYCN amplified	PATIIT	BS_2480EHNY	01
PATIIT_01_Solid Tissue_Primary Tumor	42.43	NA	NA	NBL, MYCN amplified	PATIIT	BS_GFN4FETJ	01
PATIRK_01_Solid Tissue_Primary Tumor	6.42	NA	NA	NBL, MYCN amplified	PATIRK	BS_NR090DDV	01
PATIRK_01_Solid Tissue_Primary Tumor	6.42	NA	NA	NBL, MYCN amplified	PATIRK	BS_WCEHT7D0	01
PATJDG_01_Solid Tissue_Primary Tumor	1.7	NA	NA	NBL, MYCN non-amplified	PATJDG	BS_ETC8R0TD	01
PATJDG_01_Solid Tissue_Primary Tumor	1.7	NA	NA	NBL, MYCN non-amplified	PATJDG	BS_JZFMHGNX	01
PATLBP_01_Solid Tissue_Primary Tumor	14.18	NA	NA	NBL, MYCN non-amplified	PATLBP	BS_38SSRZJ1	01
PATLBP_01_Solid Tissue_Primary Tumor	14.18	NA	NA	NBL, MYCN non-amplified	PATLBP	BS_Y2DSNJ1E	01
PATLSY_01_Solid Tissue_Primary Tumor	3.7	NA	NA	NBL, MYCN amplified	PATLSY	BS_4VKRBRJC	01
PATLSY_01_Solid Tissue_Primary Tumor	3.7	NA	NA	NBL, MYCN amplified	PATLSY	BS_F9ZXCH60	01
PATMDE_01_Solid Tissue_Primary Tumor	2.09	NA	NA	NBL, MYCN amplified	PATMDE	BS_5W25GMQ1	01
PATMDE_01_Solid Tissue_Primary Tumor	2.09	NA	NA	NBL, MYCN amplified	PATMDE	BS_BPXHZ3Y0	01
PATNKP_02_Solid Tissue_Recurrence	35.73	NA	NA	NBL, MYCN amplified	PATNKP	TARGET-30-PATNKP-02A-01D.M	02
PATNKP_02_Solid Tissue_Recurrence	35.73	NA	NA	NBL, MYCN amplified	PATNKP	TARGET-30-PATNKP-02A-01R	02
PATNUK_01_Solid Tissue_Primary Tumor	11.42	NA	NA	NBL, MYCN non-amplified	PATNUK	BS_NK1FJNRG	01
PATNUK_01_Solid Tissue_Primary Tumor	11.42	NA	NA	NBL, MYCN non-amplified	PATNUK	BS_XHSRBERM	01
PATNVA_01_Solid Tissue_Primary Tumor	12.14	NA	NA	NBL, MYCN non-amplified	PATNVA	BS_KYGRX01W	01
PATNVA_01_Solid Tissue_Primary Tumor	12.14	NA	NA	NBL, MYCN non-amplified	PATNVA	BS_S4R97RNZ	01
PATNWM_01_Solid Tissue_Primary Tumor	22.37	NA	NA	NBL, MYCN amplified	PATNWM	BS_HEKMP7BH	01
PATNWM_01_Solid Tissue_Primary Tumor	22.37	NA	NA	NBL, MYCN amplified	PATNWM	BS_R0WH31Q0	01
PATNXJ_01_Solid Tissue_Primary Tumor	28.29	NA	NA	NBL, MYCN amplified	PATNXJ	BS_GAA781GQ	01
PATNXJ_01_Solid Tissue_Primary Tumor	28.29	NA	NA	NBL, MYCN amplified	PATNXJ	BS_MH01GQ2B	01
PATNXK_01_Solid Tissue_Primary Tumor	23.59	NA	NA	NBL, MYCN amplified	PATNXK	BS_6FA0NNF1	01
PATNXK_01_Solid Tissue_Primary Tumor	23.59	NA	NA	NBL, MYCN amplified	PATNXK	BS_S0SM38BZ	01
PATNXK_01_Solid Tissue_Primary Tumor	23.59	NA	NA	NBL, MYCN amplified	PATNXK	TARGET-30-PATNXK-01A-01D	01
PATPPY_01_Solid Tissue_Primary Tumor	20.82	NA	NA	NBL, MYCN amplified	PATPPY	BS_8NQWYZHR	01
PATPPY_01_Solid Tissue_Primary Tumor	20.82	NA	NA	NBL, MYCN amplified	PATPPY	BS_T9KJYH7M	01
PATSIJ_01_Solid Tissue_Primary Tumor	19.48	NA	NA	NBL, MYCN amplified	PATSIJ	BS_DERH44Z2	01
PATSIJ_01_Solid Tissue_Primary Tumor	19.48	NA	NA	NBL, MYCN amplified	PATSIJ	BS_X3AFTRNM	01
PATSNC_01_Solid Tissue_Primary Tumor	8.33	NA	NA	NBL, MYCN amplified	PATSNC	BS_FXG6F3NN	01
PATSNC_01_Solid Tissue_Primary Tumor	8.33	NA	NA	NBL, MYCN amplified	PATSNC	BS_WKC3GR0D	01
PATSTU_01_Solid Tissue_Primary Tumor	4.33	NA	NA	NBL, MYCN amplified	PATSTU	BS_255803B6	01
PATSTU_01_Solid Tissue_Primary Tumor	4.33	NA	NA	NBL, MYCN amplified	PATSTU	BS_3D1XTG0K	01
PATSUL_01_Solid Tissue_Primary Tumor	8.57	NA	NA	NBL, MYCN amplified	PATSUL	BS_ACDQRWMY	01
PATSUL_01_Solid Tissue_Primary Tumor	8.57	NA	NA	NBL, MYCN amplified	PATSUL	BS_MG1N76FY	01
PATUBI_01_Solid Tissue_Primary Tumor	26.85	NA	NA	NBL, MYCN amplified	PATUBI	BS_E359X3QV	01
PATUBI_01_Solid Tissue_Primary Tumor	26.85	NA	NA	NBL, MYCN amplified	PATUBI	BS_E4N511ZX	01
PATUPN_01_Solid Tissue_Primary Tumor	13.36	NA	NA	NBL, MYCN non-amplified	PATUPN	BS_10MQQC5C	01
PATUPN_01_Solid Tissue_Primary Tumor	13.36	NA	NA	NBL, MYCN non-amplified	PATUPN	BS_NNH2A86D	01
PATVHJ_01_Solid Tissue_Primary Tumor	16.33	NA	NA	NBL, MYCN amplified	PATVHJ	BS_8GD69HHF	01
PATVHJ_01_Solid Tissue_Primary Tumor	16.33	NA	NA	NBL, MYCN amplified	PATVHJ	BS_EDGSP4V6	01
PATVKN_01_Solid Tissue_Primary Tumor	11.39	NA	NA	NBL, MYCN non-amplified	PATVKN	BS_6AENZKKA	01
PATVKN_01_Solid Tissue_Primary Tumor	11.39	NA	NA	NBL, MYCN non-amplified	PATVKN	BS_Z36F6GKX	01
PATWIL_01_Solid Tissue_Primary Tumor	19.1	NA	NA	NBL, MYCN amplified	PATWIL	BS_KBXSSXWF	01
PATWIL_01_Solid Tissue_Primary Tumor	19.1	NA	NA	NBL, MYCN amplified	PATWIL	BS_R66Z3ENM	01
PATWIL_01_Solid Tissue_Primary Tumor	19.1	NA	NA	NBL, MYCN amplified	PATWIL	TARGET-30-PATWIL-01A-01D	01
PATWPC_01_Solid Tissue_Primary Tumor	10.85	NA	NA	NBL, MYCN non-amplified	PATWPC	BS_25EXB29C	01
PATWPC_01_Solid Tissue_Primary Tumor	10.85	NA	NA	NBL, MYCN non-amplified	PATWPC	BS_8V59CEJJ	01
PATYIL_01_Solid Tissue_Primary Tumor	561.5	NA	NA	NBL, MYCN amplified	PATYIL	TARGET-30-PATYIL-01A-01D.M	01
PATYIL_01_Solid Tissue_Primary Tumor	561.5	NA	NA	NBL, MYCN amplified	PATYIL	TARGET-30-PATYIL-01A-01R	01
PATYIL_02_Solid Tissue_Recurrence	637.82	NA	NA	NBL, MYCN amplified	PATYIL	TARGET-30-PATYIL-02A-01D.M	02
PATYIL_02_Solid Tissue_Recurrence	637.82	NA	NA	NBL, MYCN amplified	PATYIL	TARGET-30-PATYIL-02A-01R	02
PAUCIK_01_Solid Tissue_Primary Tumor	12.05	NA	NA	NBL, MYCN non-amplified	PAUCIK	BS_FR9R7VFY	01
PAUCIK_01_Solid Tissue_Primary Tumor	12.05	NA	NA	NBL, MYCN non-amplified	PAUCIK	BS_YMWFA93F	01
PAUCNL_01_Solid Tissue_Primary Tumor	22.84	NA	NA	NBL, MYCN amplified	PAUCNL	BS_HEJAPS03	01
PAUCNL_01_Solid Tissue_Primary Tumor	22.84	NA	NA	NBL, MYCN amplified	PAUCNL	BS_KTHF096D	01
PAUCRL_01_Solid Tissue_Primary Tumor	10.42	NA	NA	NBL, MYCN non-amplified	PAUCRL	BS_PGBR1H2A	01
PAUCRL_01_Solid Tissue_Primary Tumor	10.42	NA	NA	NBL, MYCN non-amplified	PAUCRL	BS_SM1QE9FJ	01
PAUCRL_01_Solid Tissue_Primary Tumor	10.42	NA	NA	NBL, MYCN non-amplified	PAUCRL	TARGET-30-PAUCRL-01A-01D	01
PAUDDK_01_Solid Tissue_Primary Tumor	13.43	NA	NA	NBL, MYCN non-amplified	PAUDDK	TARGET-30-PAUDDK-01A-01D.M	01
PAUDDK_01_Solid Tissue_Primary Tumor	13.43	NA	NA	NBL, MYCN non-amplified	PAUDDK	TARGET-30-PAUDDK-01A-01R	01
PAUDDK_02_Solid Tissue_Recurrence	41.56	NA	NA	NBL, MYCN amplified	PAUDDK	TARGET-30-PAUDDK-02A-01D.M	02
PAUDDK_02_Solid Tissue_Recurrence	41.56	NA	NA	NBL, MYCN amplified	PAUDDK	TARGET-30-PAUDDK-02A-01R	02
PAUFHY_01_Solid Tissue_Primary Tumor	1.54	NA	NA	NBL, MYCN non-amplified	PAUFHY	BS_FXDGYFBR	01
PAUFHY_01_Solid Tissue_Primary Tumor	1.54	NA	NA	NBL, MYCN non-amplified	PAUFHY	BS_ZK0GRMB1	01
PAUGVZ_01_Solid Tissue_Primary Tumor	15.43	NA	NA	NBL, MYCN amplified	PAUGVZ	BS_J9EH31NM	01
PAUGVZ_01_Solid Tissue_Primary Tumor	15.43	NA	NA	NBL, MYCN amplified	PAUGVZ	BS_NQN1P6QY	01
PAUGVZ_01_Solid Tissue_Primary Tumor	15.43	NA	NA	NBL, MYCN amplified	PAUGVZ	TARGET-30-PAUGVZ-01A-01D	01
PAUHXD_01_Solid Tissue_Primary Tumor	22.9	NA	NA	NBL, MYCN amplified	PAUHXD	BS_NV9ZB445	01
PAUHXD_01_Solid Tissue_Primary Tumor	22.9	NA	NA	NBL, MYCN amplified	PAUHXD	BS_VV8GRGZ6	01
PAUIRD_01_Solid Tissue_Primary Tumor	27.44	NA	NA	NBL, MYCN amplified	PAUIRD	BS_02X4QTNE	01
PAUIRD_01_Solid Tissue_Primary Tumor	27.44	NA	NA	NBL, MYCN amplified	PAUIRD	BS_20HSXMYQ	01
PAUJTY_01_Solid Tissue_Primary Tumor	14.62	NA	NA	NBL, MYCN non-amplified	PAUJTY	BS_5DXK26YF	01
PAUJTY_01_Solid Tissue_Primary Tumor	14.62	NA	NA	NBL, MYCN non-amplified	PAUJTY	BS_X3F8NMS4	01
PAUJTY_01_Solid Tissue_Primary Tumor	14.62	NA	NA	NBL, MYCN non-amplified	PAUJTY	TARGET-30-PAUJTY-01A-01D	01
PAUKYI_01_Solid Tissue_Primary Tumor	1.68	NA	NA	NBL, MYCN non-amplified	PAUKYI	BS_63ACHY8K	01
PAUKYI_01_Solid Tissue_Primary Tumor	1.68	NA	NA	NBL, MYCN non-amplified	PAUKYI	BS_NV00B2Y5	01
PAULMT_01_Solid Tissue_Primary Tumor	13.26	NA	NA	NBL, MYCN non-amplified	PAULMT	BS_K59AGJKW	01
PAULMT_01_Solid Tissue_Primary Tumor	13.26	NA	NA	NBL, MYCN non-amplified	PAULMT	BS_YV3MJ2BD	01
PAULMT_01_Solid Tissue_Primary Tumor	13.26	NA	NA	NBL, MYCN non-amplified	PAULMT	TARGET-30-PAULMT-01A-01D	01
PAUNTY_01_Solid Tissue_Primary Tumor	312.62	NA	NA	NBL, MYCN amplified	PAUNTY	BS_9BZBCZHK	01
PAUNTY_01_Solid Tissue_Primary Tumor	312.62	NA	NA	NBL, MYCN amplified	PAUNTY	BS_VNKT3ZZS	01
PAUNTY_01_Solid Tissue_Primary Tumor	312.62	NA	NA	NBL, MYCN amplified	PAUNTY	TARGET-30-PAUNTY-01A-01D	01
PAUNZM_01_Solid Tissue_Primary Tumor	26.7	3	gain	NBL, MYCN amplified	PAUNZM	BS_E9YW2KHS	01
PAUNZM_01_Solid Tissue_Primary Tumor	26.7	3	gain	NBL, MYCN amplified	PAUNZM	BS_VR7XMQZ3	01
PAUPMU_01_Solid Tissue_Primary Tumor	3.07	NA	NA	NBL, MYCN amplified	PAUPMU	BS_5QFRPR61	01
PAUPMU_01_Solid Tissue_Primary Tumor	3.07	NA	NA	NBL, MYCN amplified	PAUPMU	BS_FC37XAZK	01
PAUPNR_01_Solid Tissue_Primary Tumor	21.78	NA	NA	NBL, MYCN amplified	PAUPNR	BS_2ABKFT99	01
PAUPNR_01_Solid Tissue_Primary Tumor	21.78	NA	NA	NBL, MYCN amplified	PAUPNR	BS_QCDCAX7G	01
PAURJG_01_Solid Tissue_Primary Tumor	25.32	NA	NA	NBL, MYCN amplified	PAURJG	BS_KF4AR0FG	01
PAURJG_01_Solid Tissue_Primary Tumor	25.32	NA	NA	NBL, MYCN amplified	PAURJG	BS_MMBWD5VD	01
PAUSJB_01_Solid Tissue_Primary Tumor	8.68	NA	NA	NBL, MYCN amplified	PAUSJB	BS_BJCTR4C8	01
PAUSJB_01_Solid Tissue_Primary Tumor	8.68	NA	NA	NBL, MYCN amplified	PAUSJB	BS_GB1XPW06	01
PAUSJB_01_Solid Tissue_Primary Tumor	8.68	NA	NA	NBL, MYCN amplified	PAUSJB	TARGET-30-PAUSJB-01A-01D	01
PAUUTW_01_Solid Tissue_Primary Tumor	25.81	NA	NA	NBL, MYCN amplified	PAUUTW	BS_H9BW7Y9C	01
PAUUWG_01_Solid Tissue_Primary Tumor	0.83	NA	NA	NBL, MYCN non-amplified	PAUUWG	BS_5CR48ZM7	01
PAUUWG_01_Solid Tissue_Primary Tumor	0.83	NA	NA	NBL, MYCN non-amplified	PAUUWG	BS_TGDZ491N	01
PAUVML_01_Solid Tissue_Primary Tumor	3.96	NA	NA	NBL, MYCN amplified	PAUVML	BS_591ZWG14	01
PAUVML_01_Solid Tissue_Primary Tumor	3.96	NA	NA	NBL, MYCN amplified	PAUVML	BS_VE90VKZY	01
PAUVPT_01_Solid Tissue_Primary Tumor	9.42	NA	NA	NBL, MYCN amplified	PAUVPT	BS_M7D3Q30Z	01
PAUVPT_01_Solid Tissue_Primary Tumor	9.42	NA	NA	NBL, MYCN amplified	PAUVPT	BS_XME1VS17	01
PAUWHB_01_Solid Tissue_Primary Tumor	11.54	NA	NA	NBL, MYCN non-amplified	PAUWHB	BS_NC4PWRVP	01
PAUWHB_01_Solid Tissue_Primary Tumor	11.54	NA	NA	NBL, MYCN non-amplified	PAUWHB	BS_ZPXVVM8K	01
PAUXGR_01_Solid Tissue_Primary Tumor	6.93	NA	NA	NBL, MYCN amplified	PAUXGR	BS_8MJNDM75	01
PAUXGR_01_Solid Tissue_Primary Tumor	6.93	NA	NA	NBL, MYCN amplified	PAUXGR	BS_MBNSCVMH	01
PAUYFR_01_Solid Tissue_Primary Tumor	11.97	NA	NA	NBL, MYCN non-amplified	PAUYFR	BS_5Y98E084	01
PAUYFR_01_Solid Tissue_Primary Tumor	11.97	NA	NA	NBL, MYCN non-amplified	PAUYFR	BS_BVAVPKKN	01
PAVALS_01_Solid Tissue_Primary Tumor	30.63	NA	NA	NBL, MYCN amplified	PAVALS	BS_H0MVFRCE	01
PAVALS_01_Solid Tissue_Primary Tumor	30.63	NA	NA	NBL, MYCN amplified	PAVALS	BS_NZDEF29S	01
PAVALS_01_Solid Tissue_Primary Tumor	30.63	NA	NA	NBL, MYCN amplified	PAVALS	TARGET-30-PAVALS-01A-01D	01
PAVBLZ_01_Solid Tissue_Primary Tumor	26.37	NA	NA	NBL, MYCN amplified	PAVBLZ	BS_8EG9GQZS	01
PAVBLZ_01_Solid Tissue_Primary Tumor	26.37	NA	NA	NBL, MYCN amplified	PAVBLZ	BS_PNF2SHN9	01
PAVDFW_01_Solid Tissue_Primary Tumor	0.51	NA	NA	NBL, MYCN non-amplified	PAVDFW	BS_B2BWSTJV	01
PAVDFW_01_Solid Tissue_Primary Tumor	0.51	NA	NA	NBL, MYCN non-amplified	PAVDFW	BS_Y3KBY0FY	01
PAVFNX_01_Solid Tissue_Primary Tumor	28.13	NA	NA	NBL, MYCN amplified	PAVFNX	BS_FJAQ3KAX	01
PAVFNX_01_Solid Tissue_Primary Tumor	28.13	NA	NA	NBL, MYCN amplified	PAVFNX	BS_J6FPW4H0	01
PAVHEU_01_Solid Tissue_Primary Tumor	6.12	NA	NA	NBL, MYCN amplified	PAVHEU	BS_KV05J5BX	01
PAVHEU_01_Solid Tissue_Primary Tumor	6.12	NA	NA	NBL, MYCN amplified	PAVHEU	BS_X8H38ZNB	01
PAVHGP_01_Solid Tissue_Primary Tumor	22.71	NA	NA	NBL, MYCN amplified	PAVHGP	BS_6DXDS5EE	01
PAVHGP_01_Solid Tissue_Primary Tumor	22.71	NA	NA	NBL, MYCN amplified	PAVHGP	BS_MW0JYGG1	01
PAVHWG_01_Solid Tissue_Primary Tumor	17.78	NA	NA	NBL, MYCN amplified	PAVHWG	BS_0T5A16N2	01
PAVHWG_01_Solid Tissue_Primary Tumor	17.78	NA	NA	NBL, MYCN amplified	PAVHWG	BS_KHW6ASK4	01
PAVIAZ_01_Solid Tissue_Primary Tumor	1.41	NA	NA	NBL, MYCN non-amplified	PAVIAZ	BS_4GHFYCWZ	01
PAVIAZ_01_Solid Tissue_Primary Tumor	1.41	NA	NA	NBL, MYCN non-amplified	PAVIAZ	BS_QM9CBE54	01
PAVJEG_01_Solid Tissue_Primary Tumor	5.13	NA	NA	NBL, MYCN amplified	PAVJEG	BS_70H191SN	01
PAVJEG_01_Solid Tissue_Primary Tumor	5.13	NA	NA	NBL, MYCN amplified	PAVJEG	BS_S8Q6R8MX	01
PAVJEV_01_Solid Tissue_Primary Tumor	14.22	NA	NA	NBL, MYCN non-amplified	PAVJEV	BS_HBMHZEGZ	01
PAVJEV_01_Solid Tissue_Primary Tumor	14.22	NA	NA	NBL, MYCN non-amplified	PAVJEV	BS_WBTZK7A2	01
PAVKRF_01_Solid Tissue_Primary Tumor	12.8	NA	NA	NBL, MYCN non-amplified	PAVKRF	BS_95PV1RRY	01
PAVKRF_01_Solid Tissue_Primary Tumor	12.8	NA	NA	NBL, MYCN non-amplified	PAVKRF	BS_SZ3EJPGV	01
PAVKZC_01_Solid Tissue_Primary Tumor	1.65	NA	NA	NBL, MYCN non-amplified	PAVKZC	BS_5Y7PNW71	01
PAVKZC_01_Solid Tissue_Primary Tumor	1.65	NA	NA	NBL, MYCN non-amplified	PAVKZC	BS_QWX24M4X	01
PAVLFB_01_Solid Tissue_Primary Tumor	48.11	NA	NA	NBL, MYCN amplified	PAVLFB	BS_P5VHEN5Q	01
PAVLFB_01_Solid Tissue_Primary Tumor	48.11	NA	NA	NBL, MYCN amplified	PAVLFB	BS_R232Y3SW	01
PAVMHB_01_Solid Tissue_Primary Tumor	1.03	NA	NA	NBL, MYCN non-amplified	PAVMHB	BS_YG0W2BBN	01
PAVNLK_01_Solid Tissue_Primary Tumor	27.75	NA	NA	NBL, MYCN amplified	PAVNLK	BS_135GYQQD	01
PAVNLK_01_Solid Tissue_Primary Tumor	27.75	NA	NA	NBL, MYCN amplified	PAVNLK	BS_87J6X9KJ	01
PPTC_P0061_CHLA-79_Patient Derived Xenograft_Progressive	62.14	NA	NA	NBL, MYCN amplified	PPTC_P0061	PPTC_VID4Q7JK	CHLA-79
PPTC_P0062_COG-N-415x_Patient Derived Xenograft_Progressive	2349.81	NA	NA	NBL, MYCN amplified	PPTC_P0062	PPTC_ATC9QVCW	COG-N-415x
PPTC_P0063_COG-N-421x_Patient Derived Xenograft_Relapse	865.82	NA	NA	NBL, MYCN amplified	PPTC_P0063	PPTC_LOUMEHPY	COG-N-421x
PPTC_P0064_COG-N-424x_Patient Derived Xenograft_Primary Tumor	1095.29	NA	NA	NBL, MYCN non-amplified	PPTC_P0064	PPTC_WESCL9QP	COG-N-424x
PPTC_P0065_COG-N-426x-Felix-PDX_Patient Derived Xenograft_Relapse	65.22	NA	NA	NBL, MYCN amplified	PPTC_P0065	PPTC_AZ37GWMQ	COG-N-426x-Felix-PDX
PPTC_P0066_COG-N-440x_Patient Derived Xenograft_Relapse	1245.53	NA	NA	NBL, MYCN non-amplified	PPTC_P0066	PPTC_Z83IPQ2P	COG-N-440x
PPTC_P0067_COG-N-452x_Patient Derived Xenograft_Relapse	1063.69	NA	NA	NBL, MYCN non-amplified	PPTC_P0067	PPTC_OKKFERDA	COG-N-452x
PPTC_P0067_COG-N-453x_Patient Derived Xenograft_Relapse	707	NA	NA	NBL, MYCN amplified	PPTC_P0067	PPTC_HSR1JTCY	COG-N-453x
PPTC_P0068_COG-N-471x_Patient Derived Xenograft_Relapse	1119.62	NA	NA	NBL, MYCN non-amplified	PPTC_P0068	PPTC_NEVTLBQX	COG-N-471x
PPTC_P0069_COG-N-480x_Patient Derived Xenograft_Primary Tumor	2223.08	NA	NA	NBL, MYCN amplified	PPTC_P0069	PPTC_AMXOJX4R	COG-N-480x
PPTC_P0070_COG-N-496x_Patient Derived Xenograft_Primary Tumor	653.37	NA	NA	NBL, MYCN amplified	PPTC_P0070	PPTC_PROQBSZV	COG-N-496x
PPTC_P0071_COG-N-519x_Patient Derived Xenograft_Relapse	2502.45	NA	NA	NBL, MYCN amplified	PPTC_P0071	PPTC_UKKD06QF	COG-N-519x
PPTC_P0072_COG-N-549x_Patient Derived Xenograft_Progressive	47.69	NA	NA	NBL, MYCN amplified	PPTC_P0072	PPTC_LQ6Y7A1M	COG-N-549x
PPTC_P0073_COG-N-557x_Patient Derived Xenograft_Primary Tumor	2177.22	NA	NA	NBL, MYCN amplified	PPTC_P0073	PPTC_54DHIOQ8	COG-N-557x
PPTC_P0074_COG-N-560x_Patient Derived Xenograft_Primary Tumor	1305.88	NA	NA	NBL, MYCN non-amplified	PPTC_P0074	PPTC_8IVKZKFF	COG-N-560x
PPTC_P0075_COG-N-561x_Patient Derived Xenograft_Relapse	1797.29	NA	NA	NBL, MYCN amplified	PPTC_P0075	PPTC_SL7X6FA8	COG-N-561x
PPTC_P0076_COG-N-564x_Patient Derived Xenograft_Relapse	723.45	NA	NA	NBL, MYCN amplified	PPTC_P0076	PPTC_PA8ZOTZO	COG-N-564x
PPTC_P0077_COG-N-589x_Patient Derived Xenograft_Primary Tumor	41.95	NA	NA	NBL, MYCN amplified	PPTC_P0077	PPTC_QNLYDL7E	COG-N-589x
PPTC_P0078_COG-N-590x_Patient Derived Xenograft_Primary Tumor	314.31	NA	NA	NBL, MYCN amplified	PPTC_P0078	PPTC_TPFVVATE	COG-N-590x
PPTC_P0079_COG-N-603x_Patient Derived Xenograft_Primary Tumor	425.85	NA	NA	NBL, MYCN amplified	PPTC_P0079	PPTC_ZVWIYKN9	COG-N-603x
PPTC_P0079_COG-N-623x_Patient Derived Xenograft_Progressive	717.56	NA	NA	NBL, MYCN amplified	PPTC_P0079	PPTC_9LVWBU8B	COG-N-623x
PPTC_P0080_COG-N-619x_Patient Derived Xenograft_Progressive	13.7	NA	NA	NBL, MYCN non-amplified	PPTC_P0080	PPTC_XI4JM8IG	COG-N-619x
PPTC_P0081_COG-N-620x_Patient Derived Xenograft_Progressive	51.23	NA	NA	NBL, MYCN amplified	PPTC_P0081	PPTC_OPN43SQN	COG-N-620x
PPTC_P0082_COG-N-624x_Patient Derived Xenograft_Progressive	23.32	NA	NA	NBL, MYCN amplified	PPTC_P0082	PPTC_HDGGBVIL	COG-N-624x
PPTC_P0083_COG-N-625x_Patient Derived Xenograft_Progressive	48.55	NA	NA	NBL, MYCN amplified	PPTC_P0083	PPTC_AVD76PB4	COG-N-625x
PPTC_P0165_NB-1382_Patient Derived Xenograft_Progressive	1241.53	NA	NA	NBL, MYCN non-amplified	PPTC_P0165	PPTC_IW87M9YQ	NB-1382
PPTC_P0166_NB-1643_Patient Derived Xenograft_Primary Tumor	1610.93	NA	NA	NBL, MYCN amplified	PPTC_P0166	PPTC_5YRNDC30	NB-1643
PPTC_P0167_NB-1691_Patient Derived Xenograft_Progressive	734.7	NA	NA	NBL, MYCN amplified	PPTC_P0167	PPTC_ZFRSXHVQ	NB-1691
PPTC_P0168_NB-1771_Patient Derived Xenograft_Primary Tumor	2285.16	NA	NA	NBL, MYCN amplified	PPTC_P0168	PPTC_AWZ9HDXM	NB-1771
PPTC_P0169_NB-EBc1_Patient Derived Xenograft_Progressive	65.36	NA	NA	NBL, MYCN amplified	PPTC_P0169	PPTC_0OCOQKP9	NB-EBc1
PPTC_P0170_NB-Fly-623m_Patient Derived Xenograft_Relapse	61.14	NA	NA	NBL, MYCN amplified	PPTC_P0170	PPTC_WB6OSRXV	NB-Fly-623m
PPTC_P0171_NB-SD_Patient Derived Xenograft_Progressive	1168.36	NA	NA	NBL, MYCN non-amplified	PPTC_P0171	PPTC_KB5T2UVM	NB-SD
PPTC_P0181_NCH-NB-1_Patient Derived Xenograft_Primary Tumor	38.85	NA	NA	NBL, MYCN amplified	PPTC_P0181	PPTC_WS87CENR	NCH-NB-1
PT_5SX0GRW1_7316-1927_Solid Tissue_Deceased	11.88	4	gain	NBL, MYCN non-amplified	PT_5SX0GRW1	BS_1RT76ANT	7316-1927
PT_5SX0GRW1_7316-1927_Solid Tissue_Deceased	11.88	4	gain	NBL, MYCN non-amplified	PT_5SX0GRW1	BS_KP0YNTAK	7316-1927
PT_5SX0GRW1_7316-1927_Solid Tissue_Deceased	11.88	4	gain	NBL, MYCN non-amplified	PT_5SX0GRW1	BS_Z9WJ6WW1	7316-1927
PT_9F58PWB3_7316-3960_Solid Tissue_Progressive	179.59	26	amplification	NBL, MYCN amplified	PT_9F58PWB3	BS_1D9VXFXY	7316-3960
PT_9F58PWB3_7316-3960_Solid Tissue_Progressive	179.59	26	amplification	NBL, MYCN amplified	PT_9F58PWB3	BS_YC4RWPH3	7316-3960
PT_9F58PWB3_7316-3960_Solid Tissue_Progressive	179.59	26	amplification	NBL, MYCN amplified	PT_9F58PWB3	BS_ZJGXGR1V	7316-3960
PT_DFCZAG9T_7316-224_Solid Tissue_Initial CNS Tumor	93.25	100	amplification	NBL, MYCN amplified	PT_DFCZAG9T	BS_4NPEMNAD	7316-224
PT_DFCZAG9T_7316-224_Solid Tissue_Initial CNS Tumor	93.25	100	amplification	NBL, MYCN amplified	PT_DFCZAG9T	BS_DY88N5ZT	7316-224
PT_DFCZAG9T_7316-224_Solid Tissue_Initial CNS Tumor	93.25	100	amplification	NBL, MYCN amplified	PT_DFCZAG9T	BS_H1DTKG7W	7316-224
PT_EB0D3BXG_7316-3311_Solid Tissue_Progressive	7.83	NA	NA	NBL, MYCN amplified	PT_EB0D3BXG	BS_F0GNWEJJ	7316-3311
PT_EB0D3BXG_7316-3311_Solid Tissue_Progressive	7.83	NA	NA	NBL, MYCN amplified	PT_EB0D3BXG	BS_VNWKNRY4	7316-3311
PT_EB0D3BXG_7316-3311_Solid Tissue_Progressive	7.83	NA	NA	NBL, MYCN amplified	PT_EB0D3BXG	BS_W808K35Z	7316-3311
PT_FZHGKJ0H_7316-4033_Solid Tissue_Initial CNS Tumor	0.02	NA	NA	NBL, MYCN non-amplified	PT_FZHGKJ0H	BS_0H08N9RR	7316-4033
PT_FZHGKJ0H_7316-4033_Solid Tissue_Initial CNS Tumor	0.02	NA	NA	NBL, MYCN non-amplified	PT_FZHGKJ0H	BS_JBGZ7HHZ	7316-4033
PT_FZHGKJ0H_7316-4033_Solid Tissue_Initial CNS Tumor	0.02	NA	NA	NBL, MYCN non-amplified	PT_FZHGKJ0H	BS_NHMPQ8Q1	7316-4033
PT_FZHGKJ0H_7316-4034_Solid Tissue_Initial CNS Tumor	0.18	NA	NA	NBL, MYCN non-amplified	PT_FZHGKJ0H	BS_060608PC	7316-4034
PT_FZHGKJ0H_7316-4034_Solid Tissue_Initial CNS Tumor	0.18	NA	NA	NBL, MYCN non-amplified	PT_FZHGKJ0H	BS_2SHWPB5P	7316-4034
PT_FZHGKJ0H_7316-4034_Solid Tissue_Initial CNS Tumor	0.18	NA	NA	NBL, MYCN non-amplified	PT_FZHGKJ0H	BS_5J5VH3X0	7316-4034
PT_MRTHX2AQ_7316-23_Solid Tissue_Recurrence	3.35	NA	NA	NBL, MYCN amplified	PT_MRTHX2AQ	BS_5X9HJHRE	7316-23
PT_MRTHX2AQ_7316-23_Solid Tissue_Recurrence	3.35	NA	NA	NBL, MYCN amplified	PT_MRTHX2AQ	BS_TD1ZEQ7R	7316-23
PT_P1290MMP_7316-125_Solid Tissue_Progressive	0.19	NA	NA	NBL, MYCN non-amplified	PT_P1290MMP	BS_G1Y281HX	7316-125
PT_P1290MMP_7316-125_Solid Tissue_Progressive	0.19	NA	NA	NBL, MYCN non-amplified	PT_P1290MMP	BS_ZFCXH22E	7316-125
PT_RXT6KRR6_7316-3147_Solid Tissue_Recurrence	4.68	3	gain	NBL, MYCN amplified	PT_RXT6KRR6	BS_2KYCDB13	7316-3147
PT_RXT6KRR6_7316-3147_Solid Tissue_Recurrence	4.68	3	gain	NBL, MYCN amplified	PT_RXT6KRR6	BS_CK7CPM73	7316-3147
PT_RXT6KRR6_7316-3147_Solid Tissue_Recurrence	4.68	3	gain	NBL, MYCN amplified	PT_RXT6KRR6	BS_NFRXNAFE	7316-3147
PT_RXT6KRR6_7316-3168_Solid Tissue_Recurrence	8.48	NA	NA	NBL, MYCN amplified	PT_RXT6KRR6	BS_68BZ8N6P	7316-3168
PT_RXT6KRR6_7316-3168_Solid Tissue_Recurrence	8.48	NA	NA	NBL, MYCN amplified	PT_RXT6KRR6	BS_NGAWSN7T	7316-3168
PT_W7FK539G_7316-76_Solid Tissue_Progressive	425.63	4	gain	NBL, MYCN amplified	PT_W7FK539G	BS_25VZM81R	7316-76
PT_W7FK539G_7316-76_Solid Tissue_Progressive	425.63	4	gain	NBL, MYCN amplified	PT_W7FK539G	BS_X36SF91S	7316-76
PT_W7FK539G_7316-76_Solid Tissue_Progressive	425.63	4	gain	NBL, MYCN amplified	PT_W7FK539G	BS_XBQZYS8G	7316-76
